Form 4: Replimune Group Executive Sells Shares
Insider Transaction (Form 4)
Konstantinos Xynos, Chief Medical Officer of Replimune Group, Inc., sold 11,447 shares of common stock on August 10, 2026 for $12.97 per share.
Summary
- Open-market sale: disposed of 11,447 Common Stock at $12.97 ($148,468) on August 10, 2026; holds 224,215 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $148,468 of stock on the open market.
Insider Transactions
Konstantinos Xynos — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Open-market sale | Common Stock | 11,447 | $13 | $148.5K | 224,215 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Open-market sale (11,447 shares) |
Keywords
insider transaction, Form 4, REPL, Replimune Group, Inc., bearish, Konstantinos Xynos
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.